Utility of bone marrow biopsy for rapid diagnosis of febrile illnesses in patients with human immunodeficiency virus infection

Autor: Jb, Cousar, D'Agata E, Dw, Haas, Ar, Kallianpur, Dl, Lakey, Rs, Larson, James Luther

Publikováno v: Europe PubMed Central

Histochemical staining of bone marrow biopsy samples for microorganisms may provide a presumptive diagnosis weeks before culture.To identify predictors of histochemical positivity, we reviewed 161 bone marrow biopsies from febrile patients with human

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6ec46e059e92f2a5741d9cd4f1ecd91d
http://europepmc.org/abstract/med/10923958

Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.

Autor: Amorim G, Haas DW, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Staats C, Hachey B, Turner M, Andrade BB, Rolla VC, Sterling TR

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Aug 31. Date of Electronic Publication: 2024 Aug 31.

Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles.

Autor: Nelson GW; Basic Science Program Frederick National Laboratory for Cancer Research, National Cancer Institute and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., van Duijn J; Janssen Vaccines & Prevention, Leiden, the Netherlands., Yuki Y; Basic Science Program Frederick National Laboratory for Cancer Research, National Cancer Institute and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Pau MG; Janssen Vaccines & Prevention, Leiden, the Netherlands., Tomaka F; Janssen Research and Development, Titusville, New Jersey, USA., Lavreys L; Janssen Infectious Diseases BV, Beerse, Belgium., DeRosa SC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, Washington, USA., McElrath MJ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Kirk GD; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA., Michael NL; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Haas DW; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Deeks SG; Department of Medicine, University of California, San Francisco, California, USA., Wolinsky S; Division of Infectious Diseases, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Walker B; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA., Barouch DH; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Stieh D; Janssen Vaccines & Prevention, Leiden, the Netherlands., Carrington M; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.

Publikováno v: Journal of virology [J Virol] 2024 Aug 20; Vol. 98 (8), pp. e0028124. Date of Electronic Publication: 2024 Jul 24.

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Autor: Mpofu R; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Kawuma AN; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Akpomiemie G; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Chandiwana N; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Sokhela SM; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Moorhouse M; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Venter WDF; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Post FA; King's College Hospital NHS Foundation Trust, London, UK., Haas DW; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Internal Medicine, Meharry Medical College, Nashville, Tennessee, USA., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Sinxadi P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; SAMRC/UCT Platform for Pharmacogenomics Research and Translation (PREMED) unit, Cape Town, South Africa.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 May; Vol. 90 (5), pp. 1247-1257. Date of Electronic Publication: 2024 Feb 08.

Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens.

Autor: Wu K; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Koethe J; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee., Hulgan T; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee., Brown T; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University, Baltimore, Maryland., Bares SH; Department of Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Tassiopoulos K; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Lake JE; Department of Medicine, Division of Infectious Diseases, University of Texas Health Science Center at Houston, Houston, Texas., Leonard M; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee., Samuels DC; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee., Erlandson K; Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Haas DW; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee.

Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2024 Feb 01; Vol. 34 (2), pp. 25-32. Date of Electronic Publication: 2023 Nov 01.